Work

In Brief: Subcutaneous Ocrelizumab (Ocrevus Zunovo) for Multiple Sclerosis

Year: 2024

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2024.1714b

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403296658

FWCI:

Cites:

Cited by:

Related to: 10